started · updated
Spain faces rising lung cancer diagnoses and delayed detection
The Spanish Association of Lung Cancer Patients (AEACaP) reports that more than 34,000 new lung cancer cases are expected in Spain in 2026. A significant majority, between 70% and 80%, are expected to be diagnosed in advanced stages.
The association highlights that early detection is critical for survival rates, which can reach up to 92% in minimal stages compared to much lower rates in advanced cases. Current data shows a five-year survival rate of 19.9% following diagnosis. AEACaP is calling for reduced waiting times for molecular testing and access to innovative oncological treatments.
Additionally, there is a growing trend of lung cancer affecting younger patients and non-smokers, including women. Advocates are calling for the implementation of screening programs using low-dose computed tomography (CT) scans to identify lesions in their initial stages. The report notes that lung cancer causes a high number of deaths but receives only about 4% of public oncological investment.